BioEden, the first company in the world to offer dental stem
cells preservation, started business in Mexico in 2008. Sofar,
BioEden Mexico has partnered with more that 500 renowned dentists
and today stands as the market leader with operations in the entire
country.In addition to offering dental stemcells preservation,
BioEden Mexico is promoting research programs to find clinical and
therapeutic applications for dental stem cells in various medical
The medical device sector in Mexico
reached a US$3.58 billion value
in 2010 and it is expected to reach
a US$6.87 billion value by 2015.
Healthcare provision is a high priority for the current
administration (2006- 2012). President Calderon's
National Healthcare Programme concentrates on six main
pillars: universal healthcare coverage; high care;
reinforcement of infrastructure; prevention and promotion
of health; a fair and adequate drug policy and an
effective and dynamic health regulation.
Budget-wise, the healthcare sector is one of the sectors
that has grown the most over the past years,
representing 7 per cent of the GDP. In 2011, this sector
was allocated the biggest budget in the history of Mexico.
In 2011, the federal budget authorised for the sector was
US$11,506 million, with an annual growth rate of 15
per cent between 2006 and 2011.
In addition, the medical device sector in Mexico reached a
US$3.58 billion value in 2010 and it is expected to reach
a US$6.87 value by 2015.
Within the six pillars, President Calderon's priority is to
achieve universal health coverage, by focusing on the
following four areas:
In 2007 alone, over US$3.39 million was invested in
expansion and modernisation.
A national promotion and prevention strategy.
Health Caravans, a plan that will provide medical services
for the country's most isolated communities that lack
sufficient medical infrastructure, mainly
indigenous villages and communities.
Strategy for supplying medication at health institutions;
US$324 million is now available to boost supplies at
hospitals and units in the health sector.
UK/Mexico relations in the Healthcare sector are good and
Mexico wishes to adopt the NHS model, focusing on the
fundamental concepts of free at the point of delivery and
universal coverage. Within the Healthcare sector the
pharmaceutical and MedTech market have been the most
dynamic, offering the most opportunities. This market
accounts for approximately 1.21 per cent of the national GDP,
generating US$11,376 million - a figure which
is constantly increasing.
In October 18th, 2011, President Calderon announced the new
Health Input Regulation Reform representing a significant
opportunity for the pharmaceutical industry to
develop new medicines and increase their market under the
regulation of Federal Commission for Protection from
Health Risks (COFEPRIS).
PPPs (Private and Public Partnerships).
Investment and supply of pharmaceuticals.
Training in PPP hospital management.
Training in geriatrics.
Consultancy and training for nurses.
Consultancy in institutional reform.
Quality assessment and management.
GP training in prescribing team building, management.
Primary healthcare and paramedics.
Contact and Further Information
A report on the Mexican healthcare sector as well as more
information about the specific business opportunities
can be obtained by contacting the UKTI team in Mexico
British Embassy Mexico City Tel: +52 55 1670 3243 Email:
Source - UKTI